Nonalcoholic fatty liver disease and aging: epidemiology to management.
about
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVIncreased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.Dietary Pattern Is Associated with Obesity in Older People in China: Data from China Health and Nutrition Survey (CHNS).Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Gender difference in the impact of gynoid and android fat masses on the progression of hepatic steatosis in Japanese patients with type 2 diabetesMetformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo StudiesLow-Dose Cadmium Causes Metabolic and Genetic Dysregulation Associated With Fatty Liver Disease in Mice.High fat diet and exercise lead to a disrupted and pathogenic DNA methylome in mouse liver.Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice.Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.Increased visceral adiposity with normal weight is associated with the prevalence of non-alcoholic fatty liver disease in Japanese patients with type 2 diabetesAdvanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp.Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans.Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review.Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscleA synergistic, balanced antioxidant cocktail, protects aging rats from insulin resistance and absence of meal-induced insulin sensitization (AMIS) syndrome.Novel PPARα agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging.Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease.Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis.Similarities and interactions between the ageing process and high chronic intake of added sugars.The role of autonomic dysfunction in cirrhotic patients before and after liver transplantation. Review of the literature.Possible association between Helicobacter pylori infection and nonalcoholic fatty liver disease.Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey.Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients.Sexual Dimorphism in the Age-Induced Insulin Resistance, Liver Steatosis, and Adipose Tissue Function in Rats.Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.Lipolysis stimulating peptides of potato protein hydrolysate effectively suppresses high-fat-diet-induced hepatocyte apoptosis and fibrosis in aging rats.Assessing risk of liver enzyme elevation in patients with immune-mediated diseases and different hepatitis B virus serostatus receiving anti-TNF agents: a nested case-control study.Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-Aged Adults in the Framingham Study.Apoptosis in the aging liver.Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: A population-based cross-sectional study.Cellular senescence: Implications for metabolic disease.Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?Relationship between diverticulosis and nonalcoholic fatty liver disease in elderly patients.Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease.Fatty Liver Disease, Women, and Aldosterone: Finding a Link in the Jackson Heart Study.Biochemical and Histopathological Evidence on Beneficial Effects of Standardized Extract from Tragopogon graminifolius as a Dietary Supplement in Fatty Liver: Role of Oxidative Stress.Huperzine A attenuates nonalcoholic fatty liver disease by regulating hepatocyte senescence and apoptosis: an in vitro study.Unveiling “Musica Universalis” of the Cell: A Brief History of Biological 12-Hour Rhythms.
P2860
Q28079826-64212D07-829A-48F3-BC2C-E344529CE985Q30238749-C332FDDA-6834-4472-81C9-C8BB300267C5Q30997048-EE9E8995-7B7E-42E8-A5DD-AB15F35130C1Q33602403-72FFCE77-F95C-4184-9A51-55483F11ABD7Q33844463-ACD6A13D-2348-4B86-943B-13A6702138F3Q33892867-C21C4EB8-6044-499B-B204-4078CBE9A2E8Q35941446-8B387D4D-5D80-4117-831C-92651D110CFEQ36139130-CA90934F-AFB7-437C-BB57-BD1553AA5F4EQ36196265-A2F04BEA-733C-416F-B163-0D0B6F9701C9Q36209355-22765979-1C54-4B88-B415-63101842228BQ36953626-96BB65A8-B2B8-4356-9A6D-748672902317Q37060889-743804DD-8E86-4CE0-826D-EB68CFB757A4Q37588703-8DFA717C-94C9-4B69-857D-D78F21AFEBB6Q37643487-949630C2-358F-4CA9-BEF2-B9E5AAFDEC64Q37675499-CE5FC16C-2947-4827-BE92-E8C7CD785319Q37703491-282867BE-02CB-4C85-878F-E3439915D1BFQ38311337-6AD4AFBC-51A7-4A62-9889-4746DE19AEBEQ38402537-3372DA78-1D5C-46BE-A3CA-EF28DB568AE3Q38559075-BCC9A1E1-8851-4FD6-9228-9DB6667ABABFQ38684604-FB8E6B16-70E7-40F9-9313-93B226B59404Q38782180-A5D96C73-B78C-4527-8B80-30C9DB6500B6Q38785148-2541DFCC-43D5-4876-8F5C-043EBE217963Q38972126-8C0BAA1A-F058-429C-8B9C-1B30435E577AQ39084909-CB86594F-7459-4810-B0CB-6FC5D217C655Q40893622-4C91EA38-8E4C-412F-8ABB-1F6C9CBC9455Q40974783-B5BD63C5-EBF7-4CE5-90D9-FE1032D7F422Q41328355-CC28ED74-8DB9-45D7-8475-EC24176C6AF0Q41993841-C9461D85-FE1B-4A63-B336-7774EF2B14ABQ45325449-588B44AB-B01E-4186-B0D4-E6C9895B6D6CQ46030301-B9ADB5EE-59C9-4417-8B01-10EFAE02C59AQ47104199-08BDB97E-D28C-47E9-B9A6-93FF83C0D874Q47631022-3C1C4CD3-8719-4E55-AD23-702BF399A5C0Q49069786-BF8A9770-D111-4308-AA7C-A22BCDAD4E2EQ49805564-62939A11-C1E7-4442-87F8-243EBC21BC99Q50061119-2B0BAE36-96D5-4D79-AB43-E654D6F150D9Q52728673-EDD84D8C-CFBD-4B59-AD79-167A9E7987D1Q53714410-F3D33B21-AA81-4392-ABBD-F931F0626044Q54457640-2BC3A76E-79C6-4044-AC13-5F56FCCD57B7Q55402006-A6F5F19D-DDE0-4DB8-A7F2-B7D5EB9BD408Q55411030-E8DDF433-3BD2-4A24-B34E-C1074B942285
P2860
Nonalcoholic fatty liver disease and aging: epidemiology to management.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Nonalcoholic fatty liver disease and aging: epidemiology to management.
@ast
Nonalcoholic fatty liver disease and aging: epidemiology to management.
@en
Nonalcoholic fatty liver disease and aging: epidemiology to management.
@nl
type
label
Nonalcoholic fatty liver disease and aging: epidemiology to management.
@ast
Nonalcoholic fatty liver disease and aging: epidemiology to management.
@en
Nonalcoholic fatty liver disease and aging: epidemiology to management.
@nl
prefLabel
Nonalcoholic fatty liver disease and aging: epidemiology to management.
@ast
Nonalcoholic fatty liver disease and aging: epidemiology to management.
@en
Nonalcoholic fatty liver disease and aging: epidemiology to management.
@nl
P2093
P2860
P50
P1476
Nonalcoholic fatty liver disease and aging: epidemiology to management
@en
P2093
Dante Romagnoli
Elisa Pellegrini
Enrica Baldelli
Paola Loria
P2860
P304
14185-14204
P356
10.3748/WJG.V20.I39.14185
P407
P577
2014-10-01T00:00:00Z